Acumen Research and Consulting estimates that the global antihypertensive drugs market is anticipated to reach market size of around US$ 45,000 Mn by 2027 and is anticipated to grow at a CAGR of around 5% in terms of revenue during the forecast period 2020 – 2027.
Antihypertensive drugs are employed for the treatment of patients suffering from hypertension. Hypertension is a medical condition, which involves rise in blood pressure in the arteries. Furthermore, the patient suffering from hypertension is highly susceptible to other complications, which include heart failure and aneurysm. Therefore, early diagnosis and treatment with the use of antihypertensive medications are important to treat this medical condition. The demand contains beta blockers, calcium channel antagonists and vasodilatators for some of the anti-hypertensive medications. Such medications are prescribed by the doctor and are used in drug shops and pharmacies in hospitals.
Market Insights
The global antihypertensive market growth is powered by an increase in the prevalence of hypertension across the globe. In addition, increased awareness of hypertension-related risks is another significant factor that fuels market growth. In fact, rising geriatric and sedentary lifestyles play a crucial role in the global market. But the latest expiry of the patent restricts the anti-hypertensive market from growing. In comparison, research on antihypertensive drugs in developing markets is projected to grow in the period of forecasting to provide productive opportunities.
Diuretics are Expected to Hold a Significant Market Share in the Therapeutic Class
The main therapy for hypertension in most cases is thiazide diuretics. The thiazide diuretic most commonly used in the U.S. is hydrochlorothiazide. The Joint National Hypertension Committee recommended that the thiazide-type diuretic drug, both used in isolation and along with other antihypertensive medications, such as calcium channel blockers, be one of the approved therapeutic treatment for hypertension. Moreover, more than one third of adults suffering from hypertension reported taking diuretic drugs.
Report coverage
The market research study on “Antihypertensive Drugs Market (By Therapeutic Class: Calcium Channel Blockers, Beta-adrenergic Blockers, Renin Inhibitors, ACE Inhibitors, Vasodilators, Diuretics, ARBs, Others; By Type: Primary Hypertension, Secondary Hypertension; By Distribution Channel: E-commerce Websites & Online Drug Stores, Retail Pharmacy, Hospital Pharmacy, Others) - Global Industry, Analysis, Market Size, Opportunities and Forecast, 2020 - 2027” offers detailed insights on the global antihypertensive drugs market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report also provides competitive landscape to understand the current stance of particular player. The report provides insights on global antihypertensive drugs market are drug class, type, distribution channel and major geographic regions. The antihypertensive drugs market analysis is provided for major regional markets including North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. For each region, the market size for different segments has been covered under the scope of report.
North America dominated the global antihypertensive drugs market due to the high prevalence of hypertension leading to renal and cardiovascular disorders in this region. Non-profit and public awareness-raising organizations are primarily creating opportunities to generate revenue in North America. According to the U.S. Heart Association in 2018, more men, almost half of Americans (46%), had hypertension from 32% under the previous description in the updated guidance. The prevalence of coronary disorders, inappropriate food habits, increased obesity for children as well as for adults, and high prevalence of hypertension leading to death or injury is expected to take Europe second position. Due to the rising levels of cardiovascular disease, policy initiatives for the health sector and a growing population pool, the Asia-Pacific region will witness high growth in the anti-hypertensive drug market.
Key Players
Major players included in this report Johnson and Johnson Ltd., Merck KGaA, Boehringer Ingelheim GmbH, Bayer AG, AstraZeneca plc, Pfizer, Inc., Takeda Pharmaceutical Co, Ltd.., Sanofi S.A., Daiichi Sankyo Company, Novartis International AG, and others. The reports include important trends as conventional and inorganic growth approaches in the market for anti-hypertensive drugs. Specific businesses depend on strategic growth approaches including product launches, drug approvals and other ones, like patents and events. Acquisitions and partnership & cooperation were inorganic development techniques that were illustrated on the market. Such activities opened the door to the growth of industry players' business and customer base. Business participants in the antihypertensive medicines market continue to see promising opportunities for potential development as demand for antihypertensive medicines on the global market grows.
The global antihypertensive drugs market is segmented as below:
Market Segmentation
Antihypertensive Drugs Market By Therapeutic Class
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Renin Inhibitors
- ACE Inhibitors
- Vasodilators
- Diuretics
- ARBs
- Others
Antihypertensive Drugs Market By Type
- Primary Hypertension
- Secondary Hypertension
Antihypertensive Drugs Market By Distribution Channel
- E-commerce Websites & Online Drug Stores
- Retail Pharmacy
- Hospital Pharmacy
- Others
Antihypertensive Drugs Market By Geography
North America
Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Table Of Content:
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Antihypertensive Drugs
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Antihypertensive Drugs Market By Therapeutic Class
1.2.2.1. Global Antihypertensive Drugs Market Revenue and Growth Rate Comparison By Therapeutic Class(2020-2027)
1.2.2.2. Global Antihypertensive Drugs Market Revenue Share By Therapeutic Class in 2019
1.2.2.3. Calcium Channel Blockers
1.2.2.4. Beta-adrenergic Blockers
1.2.2.5. Renin Inhibitors
1.2.2.6. ACE Inhibitors
1.2.2.7. Vasodilators
1.2.2.8. Diuretics
1.2.2.9. ARBs
1.2.2.10. Others
1.2.3. Antihypertensive Drugs Market By Type
1.2.3.1. Global Antihypertensive Drugs Market Revenue and Growth Rate Comparison By Type (2020-2027)
1.2.3.2. Global Antihypertensive Drugs Market Revenue Share By Type in 2019
1.2.3.2.1. Primary Hypertension
1.2.3.2.2. Secondary Hypertension
1.2.4. Antihypertensive Drugs Market By Distribution Channel
1.2.4.1. Global Antihypertensive Drugs Market Revenue and Growth Rate Comparison By Distribution Channel(2020-2027)
1.2.4.2. Global Antihypertensive Drugs Market Revenue Share By Distribution Channel in 2019
1.2.4.2.1. E-commerce Websites & Online Drug Stores
1.2.4.2.2. Retail Pharmacy
1.2.4.2.3. Hospital Pharmacy
1.2.4.2.4. Others
1.2.5. Antihypertensive Drugs Market By Geography
1.2.5.1. Global Antihypertensive Drugs Market Revenue and Growth Rate Comparison by Geography (2020-2027)
1.2.5.2. North America Antihypertensive Drugs Market Revenue and Growth Rate(2020-2027)
1.2.5.3. Europe Antihypertensive Drugs Market Revenue and Growth Rate(2020-2027)
1.2.5.4. Asia-Pacific Antihypertensive Drugs Market Revenue and Growth Rate(2020-2027)
1.2.5.5. Latin America Antihypertensive Drugs Market Revenue and Growth Rate(2020-2027)
1.2.5.6. Middle East and Africa (MEA)Antihypertensive Drugs Market Revenue and Growth Rate(2020-2027)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2019
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING ANTIHYPERTENSIVE DRUGS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Antihypertensive Drugs Major Manufacturers in 2019
3.2. Manufacturing Plants Distribution of Global Antihypertensive Drugs Major Manufacturers in 2019
3.3. R&D Status and Manufacturing End-User of Global Antihypertensive Drugs Major Manufacturers in 2019
3.4. Raw Materials End-Users Analysis of Global Antihypertensive Drugs Major Manufacturers in 2019
CHAPTER 4. ANTIHYPERTENSIVE DRUGS MARKET BY THERAPEUTIC CLASS
4.1. Global Antihypertensive Drugs Revenue By Therapeutic Class
4.2. Calcium Channel Blockers
4.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.3. Beta-adrenergic Blockers
4.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.4. Renin Inhibitors
4.4.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.5. ACE Inhibitors
4.5.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.6. Vasodilators
4.6.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.7. Diuretics
4.7.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.8. ARBs
4.8.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.8.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.9. Others
4.9.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.9.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
CHAPTER 5. ANTIHYPERTENSIVE DRUGS MARKET BY TYPE
5.1. Global Antihypertensive Drugs Revenue By Type
5.2. Primary Hypertension
5.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
5.3. Secondary Hypertension
5.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
CHAPTER 6. ANTIHYPERTENSIVE DRUGS MARKET BY DISTRIBUTION CHANNEL
6.1. Global Antihypertensive Drugs Revenue By Distribution Channel
6.2. E-commerce Websites & Online Drug Stores
6.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.3. Retail Pharmacy
6.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.4. Hospital Pharmacy
6.4.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.5. Others
6.5.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
CHAPTER 7. NORTH AMERICA ANTIHYPERTENSIVE DRUGS MARKET BY COUNTRY
7.1. North America Antihypertensive Drugs Market Revenue and Growth Rate, 2020 - 2027 ($Million)
7.2. North America Antihypertensive Drugs Market Revenue Share Comparison, 2020 & 2027 (%)
7.3. U.S.
7.3.1. U.S. Antihypertensive Drugs Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
7.3.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
7.3.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
7.4.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
7.4.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
CHAPTER 8. EUROPE SMART REFRIGERATOR MARKET BY COUNTRY
8.1. Europe Antihypertensive Drugs Market Revenue and Growth Rate, 2020 - 2027 ($Million)
8.2. Europe Antihypertensive Drugs Market Revenue Share Comparison, 2020 & 2027 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
8.3.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
8.3.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
8.4.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
8.4.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
8.5.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
8.5.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
8.6.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
8.6.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
8.7.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
8.7.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
CHAPTER 9. ASIA-PACIFIC ANTIHYPERTENSIVE DRUGS MARKET BY COUNTRY
9.1. Asia-Pacific Antihypertensive Drugs Market Revenue and Growth Rate, 2020 - 2027 ($Million)
9.2. Asia-Pacific Antihypertensive Drugs Market Revenue Share Comparison, 2020 & 2027 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
9.3.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
9.3.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
9.4.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
9.4.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
9.5.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
9.5.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
9.6.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
9.6.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
9.7.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
9.7.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
9.8.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
9.8.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
CHAPTER 10. LATIN AMERICA ANTIHYPERTENSIVE DRUGS MARKET BY COUNTRY
10.1. Latin America Antihypertensive Drugs Market Revenue and Growth Rate, 2020 - 2027 ($Million)
10.2. Latin America Antihypertensive Drugs Market Revenue Share Comparison, 2020 & 2027 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
10.3.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
10.3.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
10.4. Mexico
10.4.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
10.4.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
10.4.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
10.5.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
10.5.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
CHAPTER 11. MIDDLE EAST & AFRICA ANTIHYPERTENSIVE DRUGS MARKET BY COUNTRY
11.1. Middle East & Africa Antihypertensive Drugs Market Revenue and Growth Rate, 2020 - 2027 ($Million)
11.2. Middle East & Africa Antihypertensive Drugs Market Revenue Share Comparison, 2020 & 2027 (%)
11.3. GCC
11.3.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
11.3.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
11.3.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
11.4. South Africa
11.4.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
11.4.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
11.4.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
11.5. Rest of Middle East & Africa
11.5.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
11.5.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
11.5.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
CHAPTER 12. COMPANY PROFILE
12.1. Johnson and Johnson Ltd.
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Merck KGaA
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Boehringer Ingelheim GmbH
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Bayer AG
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. AstraZeneca plc
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Pfizer, Inc.
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Takeda Pharmaceutical Co, Ltd.
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Sanofi S.A.
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Daiichi Sankyo Company
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Others
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope
